bullish

Vivos Therapeutics, Inc. - Highlights of FDA Clearance in Pediatric OSA

11 Views30 Sep 2024 10:03
Issuer-paid
Chairman and CEO Kirk Huntsman joined us on the WTR Small-Cap Spotlight podcast to discuss the recent FDA clearance for a Vivos oral device in pediatric obstructive sleep apnea (OSA).
What is covered in the Full Insight:
  • Introduction
  • FDA Clearance Overview
  • Market Opportunity
  • Strategic Shift to Medical Providers
  • Technological Advances in OSA Diagnosis
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Water Tower Research
Research from Water Tower Research
Water Tower Research
Equity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x